PARIS--(BUSINESS WIRE)--Regulatory News: Due to the turnout of votes to date, ExonHit Therapeutics (Paris:ALEHT) informs its shareholders that the extraordinary shareholders’ meeting convened on Monday, June 28, 2010 to vote on the acquisition of RedPath Integrated Pathology, is unlikely to deliberate on that date for lack of quorum. In such hypothesis, the meeting will be held, on second notice, on July 8, 2010, at 16:00 CET, at the Company’s headquarters, 63-65 boulevard Masséna, 75013 Paris, France.
